Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin
Cantharidin (CTD) is the main active ingredient isolated from Mylabris, and norcantharidin (NCTD) is a demethylated derivative of CTD, which has similar antitumor activity to CTD and lower toxicity than CTD. However, the clinical use of NCTD is limited due to its poor solubility, low bioavailability...
Main Authors: | Qian Liu, Henglai Sun, Xinyu Li, Huagang Sheng, Liqiao Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/22/7740 |
Similar Items
-
Novel Strategies for Solubility and Bioavailability Enhancement of Bufadienolides
by: Huili Shao, et al.
Published: (2021-12-01) -
Highly Water-Soluble Solid Dispersions of Honokiol: Preparation, Solubility, and Bioavailability Studies and Anti-Tumor Activity Evaluation
by: Li Wang, et al.
Published: (2019-11-01) -
Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells
by: Gabriel Martínez-Razo, et al.
Published: (2023-03-01) -
Norcantharidin-Encapsulated C60-Modified Nanomicelles: A Potential Approach to Mitigate Cytotoxicity in Renal Cells and Simultaneously Enhance Anti-Tumor Activity in Hepatocellular Carcinoma Cells
by: Zhongpeng Ding, et al.
Published: (2023-11-01) -
A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma
by: Ming-Hua Xie, et al.
Published: (2022-09-01)